Tag: hemostats and tissue sealants market insights

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

Hemostats And Tissue Sealants Market CAGR Outlook And Future Development

The hemostats and tissue sealants market size has exhibited robust growth over the past few years. Projections indicate that it will increase from $4.35 billion in 2025 to $4.64 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.7%. Key drivers of this historical growth include the widespread use of traditional mechanical hemostats, the constrained supply of synthetic sealants, a rise in the number of surgical operations, the development of hospital infrastructure, and the early incorporation of fibrin-based sealants.

The hemostats and tissue sealants market size is anticipated to undergo significant expansion in the upcoming years. It is projected to reach $5.97 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%. The projected increase during this period is attributable to the emergence of next-generation tissue adhesives, an escalation in minimally invasive surgeries, a rise in cardiovascular and trauma surgeries, intensified research into hemostasis technologies, and the broadened reach of direct and online distribution channels. Prominent developments in the forecast period encompass a growing embrace of advanced hemostatic products, increased utilization of synthetic and combination sealants, an expansion of cardiovascular and trauma surgeries, a focus on minimally invasive procedures for faster recovery, and the increasing application of research and academic studies in hemostasis.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=74054607&type=smp&name=Hemostats%20And%20Tissue%20Sealants%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Hemostats And Tissue Sealants Market Industry Drivers: What’s Behind The Revenue Growth?

The increasing volume of surgical procedures is anticipated to fuel the growth of the hemostats and tissue sealants market moving forward. Surgical procedures refer to medical operations that involve manual and instrumental techniques carried out by surgeons to diagnose, treat, or remove diseased tissues or organs, or to repair bodily functions. The uptick in surgical procedures is attributed to the rising prevalence of chronic diseases, which frequently demand surgical intervention for effective management, treatment, or to prevent complications. Hemostats and tissue sealants support surgical procedures by effectively managing bleeding and sealing tissues, thereby minimizing complications and improving patient outcomes. For instance, in June 2024, the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based professional body for board-certified aesthetic plastic surgeons, reported a 5.5% rise in surgical procedures in 2023, with more than 15.8 million surgeries and 19.1 million non-surgical procedures performed globally. Therefore, the escalating number of surgical procedures is driving the expansion of the hemostats and tissue sealants market.

Hemostats And Tissue Sealants Market Segmentation: How Does The Market Break Down By Category?

The hemostats and tissue sealants market covered in this report is segmented –

1) By Product Type: Topical Hemostats, Adhesives And Tissue Sealants, Fibrin Sealants, Other Product Types

2) By Composition: Biological Based, Synthetic Based, Combination

3) By Distribution Channel: Direct Sales, Distributors, Online Sales

4) By Application: Surgical Procedures, Trauma Cases, Cardiovascular Surgery, General Surgery, Other Applications

5) By End-Users: Hospitals, Ambulatory Surgical Centers (ASCs), Specialized Clinics, Research And Academic Institutes

Subsegments:

1) By Topical Hemostats: Mechanical Hemostats, Active Hemostats, Flowable Hemostats, Combination Hemostats

2) By Adhesives And Tissue Sealants: Synthetic Tissue Adhesives, Biological Tissue Adhesives, Cyanoacrylate-Based Adhesives

3) By Fibrin Sealants: Liquid Fibrin Sealants, Patch-Based Fibrin Sealants

4) By Other Product Types: Gelatin-Based Hemostats, Collagen-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats

#Hemostats And Tissue Sealants Market Growth Trends: What’s Shaping The Future Outlook?

Major companies operating in the hemostat and tissue sealants market are prioritizing the development of advanced products, such as ready-to-use absorbable collagen pads for hemostasis, to enhance efficiency and improve outcomes in surgical care. These ready-to-use absorbable collagen pads incorporate bioactive, resorbable materials that allow for immediate application without preparation, thereby enabling quick and effective tissue and dura sealing, as well as hemostasis. For instance, in April 2025, Baxter International Inc., a US-based healthcare company, introduced its Hemopatch Sealing Hemostat, which offers room temperature storage, at a symposium held in Austria. This new room temperature Hemopatch sealing hemostat provides ready-to-use convenience by eliminating the need for pre-warming, allowing for rapid application during surgery. It is an innovative absorbable pad that can be directly applied during both open and minimally invasive surgeries, removing any requirements for product preparation or refrigeration. The product’s powerful adhesive properties, extended shelf life, and rapid hemostatic effect assist surgeons in more efficiently managing bleeding or leakage, ultimately supporting improved surgical precision and patient recovery across various specialties.

Hemostats And Tissue Sealants Market Competitive Landscape: Who Leads The Industry?

Major companies operating in the hemostats and tissue sealants market are Johnson & Johnson, Medtronic plc, Becton Dickinson and Company (BD), Stryker Corporation, Baxter International Inc., Meril Life Sciences Pvt. Ltd., Teleflex Incorporated, Integra LifeSciences Holdings Corporation, Corza Medical Inc., Artivion Inc., Ethicon Inc., Advanced Medical Solutions Group plc, Marine Polymer Technologies Inc., Samyang Holdings Corporation, 3-D Matrix Medical Technology Co Ltd., GELITA AG, BioCer Entwicklungs-GmbH, AEGIS Lifesciences Pvt. Ltd., Betatech Medical Ltd., Cohera Medical Inc.

View The Full Hemostats And Tissue Sealants Market Report:

https://thebusinessresearchcompany.com/report/hemostats-and-tissue-sealants-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Hemostats And Tissue Sealants Market Geographic Landscape: Which Region Dominates Industry Growth?

North America was the largest region in the hemostats and tissue sealants market in 2025. The regions covered in the hemostats and tissue sealants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

The market for hemostats and tissue sealants has shown impressive growth over recent years, reflecting an increasing demand driven by advancements in surgical techniques and healthcare infrastructure. This overview explores the current market size, growth drivers, key segments, innovation trends, leading players, and regional dynamics shaping the future of this critical medical sector.

Hemostats and Tissue Sealants Market Size and Projected Growth

The hemostats and tissue sealants market has expanded significantly, with its value expected to rise from $4.35 billion in 2025 to $4.64 billion in 2026, marking a compound annual growth rate (CAGR) of 6.7%. This expansion during the historical period stems from a heavy reliance on traditional mechanical hemostats, limited synthetic sealant options, increasing surgical volumes, enhanced hospital infrastructure, and early adoption of fibrin-based sealants. Looking ahead, the market is forecast to grow further, reaching $5.97 billion by 2030 with a CAGR of 6.5%. Driving this future growth are innovations in next-generation tissue adhesives, a rise in minimally invasive and cardiovascular surgeries, expanded research in hemostasis technologies, and broader distribution channels, including direct and online sales. Key market trends include increased use of synthetic and combination sealants, growth in cardiovascular and trauma surgeries, emphasis on faster recovery techniques, and greater research applications in hemostasis.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25781&type=smp

Primary Factors Boosting Hemostats and Tissue Sealants Market Expansion

A major contributor to the market’s growth is the rising volume of surgical procedures worldwide. These surgeries—encompassing manual and instrumental techniques performed to diagnose, treat, or repair organs and tissues—are becoming more frequent due to the growing prevalence of chronic diseases that often require surgical intervention for effective management. Hemostats and tissue sealants play a crucial role in such procedures by controlling bleeding and sealing tissues, thereby reducing complications and improving outcomes. For instance, according to the International Society of Aesthetic Plastic Surgery (ISAPS), June 2024 data revealed a 5.5% increase in surgical procedures in 2023, with over 15.8 million surgeries and 19.1 million non-surgical treatments performed globally. This trend clearly supports the expanding demand within the hemostats and tissue sealants market.

Emerging Developments in Surgical Techniques That Propel Market Demand

The surge in minimally invasive surgeries is another important market driver. These procedures offer faster recovery and fewer complications, creating a higher need for advanced hemostatic and sealing products. Additionally, the rise in cardiovascular and trauma surgeries further fuels the demand for effective hemostats and tissue sealants, as these interventions require precise bleeding control and tissue sealing to ensure patient safety and surgical success.

Access The Complete Hemostats And Tissue Sealants Market Report:

https://www.thebusinessresearchcompany.com/report/hemostats-and-tissue-sealants-global-market-report

Hemostats and Tissue Sealants Market: Breakdown of Leading Product and Application Segments

This market is segmented across several categories to address diverse clinical needs:

1) By Product Type: Topical Hemostats, Adhesives and Tissue Sealants, Fibrin Sealants, and Other Products

2) By Composition: Biological-Based, Synthetic-Based, and Combination Types

3) By Distribution Channel: Direct Sales, Distributors, and Online Sales

4) By Application: Surgical Procedures, Trauma Cases, Cardiovascular Surgery, General Surgery, and Others

5) By End-User: Hospitals, Ambulatory Surgical Centers (ASCs), Specialized Clinics, and Research & Academic Institutes

Further subdivisions include:

– Topical Hemostats: Mechanical, Active, Flowable, and Combination Hemostats

– Adhesives and Tissue Sealants: Synthetic, Biological, and Cyanoacrylate-Based Adhesives

– Fibrin Sealants: Liquid and Patch-Based Types

– Other Products: Gelatin-Based, Collagen-Based, and Oxidized Regenerated Cellulose-Based Hemostats

Innovation Trends Advancing the Hemostats and Tissue Sealants Market

Key players in the market are focusing on introducing cutting-edge products to enhance surgical efficiency and patient outcomes. A notable innovation is the development of ready-to-use absorbable collagen pads that facilitate quick application without preparation. These pads are bioactive and resorbable, offering effective tissue sealing and hemostasis. For example, in April 2025, Baxter International Inc. launched the Hemopatch Sealing Hemostat at a surgical symposium in Austria. This product stands out for its room temperature storage capabilities and immediate usability without pre-warming, making it suitable for both open and minimally invasive surgeries. Features such as strong adhesive properties, extended shelf life, and rapid hemostatic effect allow surgeons to better manage bleeding and leakage, improving precision and accelerating patient recovery.

Key Market Players and Their Strategic Roles in the Hemostats and Tissue Sealants Sector

The competitive landscape of the hemostats and tissue sealants market includes influential companies such as Johnson & Johnson, Medtronic plc, Becton Dickinson and Company (BD), Stryker Corporation, Baxter International Inc., Meril Life Sciences Pvt. Ltd., Teleflex Incorporated, Integra LifeSciences Holdings Corporation, Corza Medical Inc., Artivion Inc., Ethicon Inc., Advanced Medical Solutions Group plc, Marine Polymer Technologies Inc., Samyang Holdings Corporation, 3-D Matrix Medical Technology Co Ltd., GELITA AG, BioCer Entwicklungs-GmbH, AEGIS Lifesciences Pvt. Ltd., Betatech Medical Ltd., and Cohera Medical Inc., among others. These organizations are continuously innovating and expanding their product portfolios to maintain a leading edge in this dynamic healthcare market.

Regional Perspective on Hemostats and Tissue Sealants Market Growth

In 2025, North America held the largest share of the hemostats and tissue sealants market, driven by advanced healthcare infrastructure and high surgical procedure volumes. The market analysis also encompasses key regions such as Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East, and Africa, highlighting diverse growth opportunities and regional demand variations. The Asia-Pacific region, in particular, is expected to demonstrate notable growth potential in the coming years due to increasing healthcare investments and rising surgical rates.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Expansion In Market Value Is Forecasted For The Hemostats And Tissue Sealants Market Between 2026 And 2030?

The hemostats and tissue sealants market size has experienced significant growth in recent years. It is projected to expand from $4.35 billion in 2025 to $4.64 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.7%. Historically, this growth can be attributed to factors such as the reliance on traditional mechanical hemostats, the limited availability of synthetic sealants, an increase in surgical procedures, the development of hospital infrastructure, and the early adoption of fibrin-based sealants.

The hemostats and tissue sealants market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a valuation of $5.97 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.5%. The predicted growth during this period stems from several factors, including the creation of advanced tissue adhesives, an increase in minimally invasive surgical procedures, the rising prevalence of cardiovascular and trauma surgeries, enhanced research efforts in hemostasis technologies, and the broadening of direct and online sales avenues. Key developments expected within this forecast timeframe encompass the increasing embrace of sophisticated hemostatic solutions, a surge in the application of synthetic and hybrid sealants, the continued expansion of cardiovascular and trauma operations, an emphasis on procedures that are minimally invasive and promote quicker recovery, and an uptick in research and academic endeavors related to hemostasis.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25781&type=smp

Which Drivers Are Supporting The Hemostats And Tissue Sealants Market Growth?

The rising number of surgical procedures is projected to propel the growth of the hemostats and tissue sealants market in the future. Surgical procedures are medical operations that involve manual and instrumental techniques performed by surgeons to diagnose, treat, or remove diseased tissues or organs, or to repair bodily functions. The increase in surgical procedures is attributed to the growing prevalence of chronic diseases, which often require surgical intervention for effective management, treatment, or complication prevention. Hemostats and tissue sealants assist surgical procedures by effectively controlling bleeding and sealing tissues, thereby reducing complications and improving surgical outcomes. For instance, in June 2024, according to the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based professional body for board-certified aesthetic plastic surgeons, there was a 5.5% rise in surgical procedures in 2023, with more than 15.8 million surgeries and 19.1 million non-surgical procedures performed globally. Therefore, the rising number of surgical procedures is driving the growth of the hemostats and tissue sealants market.

What Segment Categories Shape The Hemostats And Tissue Sealants Market Segment Landscape?

The hemostats and tissue sealants market covered in this report is segmented –

1) By Product Type: Topical Hemostats, Adhesives And Tissue Sealants, Fibrin Sealants, Other Product Types

2) By Composition: Biological Based, Synthetic Based, Combination

3) By Distribution Channel: Direct Sales, Distributors, Online Sales

4) By Application: Surgical Procedures, Trauma Cases, Cardiovascular Surgery, General Surgery, Other Applications

5) By End-Users: Hospitals, Ambulatory Surgical Centers (ASCs), Specialized Clinics, Research And Academic Institutes

Subsegments:

1) By Topical Hemostats: Mechanical Hemostats, Active Hemostats, Flowable Hemostats, Combination Hemostats

2) By Adhesives And Tissue Sealants: Synthetic Tissue Adhesives, Biological Tissue Adhesives, Cyanoacrylate-Based Adhesives

3) By Fibrin Sealants: Liquid Fibrin Sealants, Patch-Based Fibrin Sealants

4) By Other Product Types: Gelatin-Based Hemostats, Collagen-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats

Which Trends Are Expected To Impact The Hemostats And Tissue Sealants Market?

Leading firms within the hemostat and tissue sealants market are concentrating their efforts on creating sophisticated products, like immediate-use absorbable collagen pads hemostat, aimed at enhancing effectiveness and results in surgical procedures. These immediate-use absorbable collagen pads of hemostat contain bioactive, resorbable substances that allow for instant application, removing the need for prior preparation, thereby facilitating rapid and efficient sealing of tissue and dura, alongside achieving hemostasis. As an illustration, in April 2025, Baxter International Inc., a US-based healthcare firm, introduced the Hemopatch Sealing Hemostat, designed for room temperature storage, during a symposium held in Austria. The innovative room temperature Hemopatch sealing hemostat provides the advantage of being ready-to-use without requiring pre-warming, which allows for swift application during surgical operations. This product is an advanced absorbable pad that can be directly applied in both open and minimally invasive surgical settings, thereby removing any necessity for product preparation or refrigeration. Its robust adhesive qualities, prolonged shelf life, and fast hemostatic action assist surgeons in more effectively managing bleeding or leakage, ultimately contributing to enhanced surgical precision and patient recuperation across a diverse range of medical specialties.

Who Are The Companies Operating Across The Hemostats And Tissue Sealants Market Value Chain?

Major companies operating in the hemostats and tissue sealants market are Johnson & Johnson, Medtronic plc, Becton Dickinson and Company (BD), Stryker Corporation, Baxter International Inc., Meril Life Sciences Pvt. Ltd., Teleflex Incorporated, Integra LifeSciences Holdings Corporation, Corza Medical Inc., Artivion Inc., Ethicon Inc., Advanced Medical Solutions Group plc, Marine Polymer Technologies Inc., Samyang Holdings Corporation, 3-D Matrix Medical Technology Co Ltd., GELITA AG, BioCer Entwicklungs-GmbH, AEGIS Lifesciences Pvt. Ltd., Betatech Medical Ltd., Cohera Medical Inc.

Get The Full Hemostats And Tissue Sealants Market Report:

https://www.thebusinessresearchcompany.com/report/hemostats-and-tissue-sealants-global-market-report

Which Region Is The Largest In The Hemostats And Tissue Sealants Market?

North America was the largest region in the hemostats and tissue sealants market in 2025. The regions covered in the hemostats and tissue sealants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Hemostats And Tissue Sealants Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=25781&type=smp

Browse Through More Reports Similar to the Global Hemostats And Tissue Sealants Market 2026, By The Business Research Company

Absorbable Hemostats Market Report 2026

https://www.thebusinessresearchcompany.com/report/absorbable-hemostats-global-market-report

Hemostasis Products Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemostasis-products-global-market-report

Hemostasis Diagnostic Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemostasis-diagnostic-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Growth Is Projected For The Hemostats And Tissue Sealants Market During The Forecast Period 2026–2030?

The hemostats and tissue sealants market has experienced significant expansion in recent years. Its valuation is predicted to increase from $4.35 billion in 2025 to $4.64 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.7%. The growth observed in the past can be ascribed to factors like the reliance on traditional mechanical hemostats, the limited availability of synthetic sealants, an increase in surgical procedures, the expansion of hospital infrastructure, and the early adoption of fibrin-based sealants.

The hemostats and tissue sealants market is projected to experience substantial expansion over the coming years. This market is set to reach a value of $5.97 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.5%. Factors contributing to this growth during the forecast period include advancements in next-generation tissue adhesives, an increase in minimally invasive surgeries, a rise in cardiovascular and trauma surgeries, intensified research in hemostasis technologies, and the broadening of direct and online distribution channels. Key trends anticipated during this period encompass the growing acceptance of advanced hemostatic products, greater utilization of synthetic and combination sealants, an increase in cardiovascular and trauma surgeries, an emphasis on minimally invasive procedures for quicker recovery, and expanding research and academic applications within hemostasis.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25781&type=smp

Which Economic Or Industry Drivers Are Impacting The Hemostats And Tissue Sealants Market?

An increasing volume of surgical operations is projected to advance the expansion of the hemostats and tissue sealants market in the upcoming period. Surgical procedures are defined as medical interventions that involve manual and instrumental techniques utilized by surgeons to diagnose, treat, or remove diseased tissues or organs, or to repair bodily functions. The uptick in surgical procedures is attributable to the rising prevalence of chronic diseases, which frequently demand surgical intervention for their effective management, treatment, or prevention of complications. Hemostats and tissue sealants facilitate surgical procedures by efficiently managing bleeding and sealing tissues, thereby minimizing complications and elevating surgical outcomes. For instance, in June 2024, according to the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based professional body for board-certified aesthetic plastic surgeons, there was a 5.5% rise in surgical procedures in 2023, with more than 15.8 million surgeries and 19.1 million non-surgical procedures performed globally. Thus, the growing number of surgical procedures is fostering the development of the hemostats and tissue sealants market.

What Market Segments Are Evaluated Within The Hemostats And Tissue Sealants Market?

The hemostats and tissue sealants market covered in this report is segmented –

1) By Product Type: Topical Hemostats, Adhesives And Tissue Sealants, Fibrin Sealants, Other Product Types

2) By Composition: Biological Based, Synthetic Based, Combination

3) By Distribution Channel: Direct Sales, Distributors, Online Sales

4) By Application: Surgical Procedures, Trauma Cases, Cardiovascular Surgery, General Surgery, Other Applications

5) By End-Users: Hospitals, Ambulatory Surgical Centers (ASCs), Specialized Clinics, Research And Academic Institutes

Subsegments:

1) By Topical Hemostats: Mechanical Hemostats, Active Hemostats, Flowable Hemostats, Combination Hemostats

2) By Adhesives And Tissue Sealants: Synthetic Tissue Adhesives, Biological Tissue Adhesives, Cyanoacrylate-Based Adhesives

3) By Fibrin Sealants: Liquid Fibrin Sealants, Patch-Based Fibrin Sealants

4) By Other Product Types: Gelatin-Based Hemostats, Collagen-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats

What Industry Trends Are Redefining The Hemostats And Tissue Sealants Market?

Major companies active in the hemostat and tissue sealants market are concentrating on developing advanced products, such as ready-to-use absorbable collagen pads hemostat, to boost efficiency and improve outcomes in surgical care. Ready-to-use absorbable collagen pads of hemostat incorporate bioactive, resorbable materials that allow for immediate application without preparation, facilitating quick and effective tissue and dura sealing as well as hemostasis. For instance, in April 2025, Baxter International Inc., a US-based healthcare company, unveiled Hemopatch Sealing Hemostat with room temperature storage at a symposium in Austria. This new room temperature Hemopatch sealing hemostat offers ready-to-use convenience without the need for pre-warming, enabling rapid application during surgery. It is an innovative absorbable pad that can be applied directly during both open and minimally invasive surgeries, removing the need for product preparation or refrigeration. The product’s strong adhesive properties, extended shelf life, and rapid hemostatic effect assist surgeons in managing bleeding or leakage more efficiently, ultimately supporting enhanced surgical precision and patient recovery across various specialties.

Who Are The Top Market Participants Influencing The Hemostats And Tissue Sealants Market?

Major companies operating in the hemostats and tissue sealants market are Johnson & Johnson, Medtronic plc, Becton Dickinson and Company (BD), Stryker Corporation, Baxter International Inc., Meril Life Sciences Pvt. Ltd., Teleflex Incorporated, Integra LifeSciences Holdings Corporation, Corza Medical Inc., Artivion Inc., Ethicon Inc., Advanced Medical Solutions Group plc, Marine Polymer Technologies Inc., Samyang Holdings Corporation, 3-D Matrix Medical Technology Co Ltd., GELITA AG, BioCer Entwicklungs-GmbH, AEGIS Lifesciences Pvt. Ltd., Betatech Medical Ltd., Cohera Medical Inc.

Read the full hemostats and tissue sealants market report here:

https://www.thebusinessresearchcompany.com/report/hemostats-and-tissue-sealants-global-market-report

What Are The Top-Performing Regions Within The Hemostats And Tissue Sealants Market?

North America was the largest region in the hemostats and tissue sealants market in 2025. The regions covered in the hemostats and tissue sealants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Hemostats And Tissue Sealants Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=25781&type=smp

Browse Through More Reports Similar to the Global Hemostats And Tissue Sealants Market 2026, By The Business Research Company

Absorbable Hemostats Market Report 2026

https://www.thebusinessresearchcompany.com/report/absorbable-hemostats-global-market-report

Hemostasis Products Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemostasis-products-global-market-report

Hemostasis Diagnostic Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemostasis-diagnostic-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company

What upper market value could the Hemostats And Tissue Sealants Market reach by 2030 starting from 2026 levels?

The hemostats and tissue sealants market has experienced significant growth in recent years. Its value is anticipated to increase from $4.35 billion in 2025 to $4.64 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.7%. The expansion observed during the historic period can be attributed to factors such as a reliance on traditional mechanical hemostats, the limited availability of synthetic sealants, an increase in surgical procedures, the development of hospital infrastructure, and the early adoption of fibrin-based sealants.

The hemostats and tissue sealants market is anticipated to experience substantial expansion in the coming years. This market is projected to reach $5.97 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.5%. This projected growth is driven by factors such as the creation of advanced tissue adhesives, an increase in minimally invasive surgical procedures, the rising frequency of cardiovascular and trauma surgeries, enhanced research efforts in hemostasis technologies, and the broadening of direct and online sales avenues. Key trends for this period encompass the increasing acceptance of sophisticated hemostatic solutions, a greater reliance on synthetic and hybrid sealants, the continued expansion of cardiovascular and trauma surgical interventions, an emphasis on procedures that are minimally invasive and facilitate quicker recovery, and the expanding role of research and academic studies in hemostasis.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25781&type=smp

Which Drivers Are Influencing Long-Term Growth In The Hemostats And Tissue Sealants Market?

The increasing volume of surgical operations is anticipated to fuel the expansion of the hemostats and tissue sealants market in the future. Surgical procedures encompass medical interventions where surgeons employ manual and instrumental methods to diagnose ailments, treat conditions, extract diseased tissues or organs, or restore bodily functions. This increase in surgeries stems from the growing incidence of chronic illnesses, which frequently necessitate surgical interventions for proper management, therapy, or to avert complications. Hemostats and tissue sealants play a crucial role in surgical operations by efficiently managing hemorrhage and sealing tissues, consequently diminishing complications and enhancing patient recovery. For example, data from June 2024, provided by the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based professional organization for aesthetic plastic surgeons, indicated a 5.5% growth in surgical procedures in 2023, totaling over 15.8 million surgeries and 19.1 million non-surgical procedures conducted globally. Consequently, the expanding volume of surgical interventions is a primary impetus for the growth of the hemostats and tissue sealants market.

Which Segments Are Driving Activity In The Hemostats And Tissue Sealants Market?

The hemostats and tissue sealants market covered in this report is segmented –

1) By Product Type: Topical Hemostats, Adhesives And Tissue Sealants, Fibrin Sealants, Other Product Types

2) By Composition: Biological Based, Synthetic Based, Combination

3) By Distribution Channel: Direct Sales, Distributors, Online Sales

4) By Application: Surgical Procedures, Trauma Cases, Cardiovascular Surgery, General Surgery, Other Applications

5) By End-Users: Hospitals, Ambulatory Surgical Centers (ASCs), Specialized Clinics, Research And Academic Institutes

Subsegments:

1) By Topical Hemostats: Mechanical Hemostats, Active Hemostats, Flowable Hemostats, Combination Hemostats

2) By Adhesives And Tissue Sealants: Synthetic Tissue Adhesives, Biological Tissue Adhesives, Cyanoacrylate-Based Adhesives

3) By Fibrin Sealants: Liquid Fibrin Sealants, Patch-Based Fibrin Sealants

4) By Other Product Types: Gelatin-Based Hemostats, Collagen-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats

How Are New Market Trends Shaping The Landscape Of The Hemostats And Tissue Sealants Market?

Major companies active in the hemostat and tissue sealants market are prioritizing the development of advanced offerings, such as pre-prepared absorbable collagen pad hemostats, to elevate efficiency and outcomes in surgical care. These ready-to-use absorbable collagen pads, functioning as hemostats, utilize bioactive and resorbable materials, allowing for immediate application without prior preparation, which facilitates quick and effective sealing of tissues and dura, as well as hemostasis. For instance, in April 2025, Baxter International Inc., a US-based healthcare organization, unveiled its Hemopatch Sealing Hemostat designed for room temperature storage during a symposium in Austria. This new room temperature Hemopatch sealing hemostat offers the convenience of being ready-to-use without requiring pre-warming, enabling rapid deployment during operations. It is an innovative absorbable pad that can be applied directly during both open and minimally invasive surgeries, eliminating any need for product preparation or refrigeration. The product’s strong adhesive characteristics, extended shelf life, and swift hemostatic effect empower surgeons to manage bleeding or leakage more proficiently, ultimately bolstering surgical precision and patient recovery across diverse medical disciplines.

Which Key Players Are Driving Competition In The Hemostats And Tissue Sealants Market?

Major companies operating in the hemostats and tissue sealants market are Johnson & Johnson, Medtronic plc, Becton Dickinson and Company (BD), Stryker Corporation, Baxter International Inc., Meril Life Sciences Pvt. Ltd., Teleflex Incorporated, Integra LifeSciences Holdings Corporation, Corza Medical Inc., Artivion Inc., Ethicon Inc., Advanced Medical Solutions Group plc, Marine Polymer Technologies Inc., Samyang Holdings Corporation, 3-D Matrix Medical Technology Co Ltd., GELITA AG, BioCer Entwicklungs-GmbH, AEGIS Lifesciences Pvt. Ltd., Betatech Medical Ltd., Cohera Medical Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/hemostats-and-tissue-sealants-global-market-report

Which Region Is Projected To Lead The Hemostats And Tissue Sealants Market During The Forecast Period?

North America was the largest region in the hemostats and tissue sealants market in 2025. The regions covered in the hemostats and tissue sealants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Hemostats And Tissue Sealants Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=25781&type=smp

Browse Through More Reports Similar to the Global Hemostats And Tissue Sealants Market 2026, By The Business Research Company

Absorbable Hemostats Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/absorbable-hemostats-global-market-report

Hemostasis Products Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemostasis-products-global-market-report

Hemostasis Diagnostic Devices And Equipment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemostasis-diagnostic-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Global Market Value Of The Hemostats And Tissue Sealants Industry In 2025?

The hemostats and tissue sealants market has experienced robust growth in recent years. It is projected to expand from $4.07 billion in 2024 to $4.35 billion by 2025, achieving a compound annual growth rate (CAGR) of 6.9%. Historically, this growth can be attributed to an expanding geriatric population, a rising incidence of trauma and accidents, an increasing prevalence of cardiovascular disorders, greater investments in medical, and the increasing adoption of minimally invasive surgeries.

The hemostats and tissue sealants market is projected to experience substantial expansion in the coming years. This market is predicted to reach a size of $5.61 billion by 2029, growing at a compound annual growth rate (CAGR) of 6.6%. The anticipated growth during this period stems from several factors, including the expanded application of hemostats in ambulatory surgical centers, a rising need for biocompatible and synthetic sealants, increased capital allocation for surgical advancements and research and development, heightened understanding of blood management protocols in surgical procedures, and a general increase in healthcare spending. Key trends expected during the forecast timeframe encompass progress in synthetic polymer technology, innovative drug-delivery sealants driven by technological advancements, the incorporation of hemostatic agents into minimally invasive surgical techniques, the evolution of dual-action sealants and hemostats, and breakthroughs in bioengineered and biocompatible materials.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25781&type=smp

Which Industry Drivers Are Expected To Accelerate The Hemostats And Tissue Sealants Market From 2025 To 2029?

An increasing volume of surgical operations is anticipated to drive the future expansion of the hemostats and tissue sealants market. Surgical procedures are medical interventions performed by surgeons using manual and instrumental techniques to diagnose, treat, or remove diseased tissues or organs, or to restore bodily functions. This rise in surgical procedures is attributed to the growing prevalence of chronic diseases, which frequently necessitate surgical intervention for effective management, treatment, or complication prevention. Hemostats and tissue sealants play a crucial role in surgical procedures by effectively managing bleeding and sealing tissues, thereby minimizing complications and enhancing surgical outcomes. For instance, in June 2024, the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based professional body for board-certified aesthetic plastic surgeons, reported a 5.5% rise in surgical procedures in 2023, with more than 15.8 million surgeries and 19.1 million non-surgical procedures performed globally. Thus, the increasing number of surgical procedures is propelling the growth of the hemostats and tissue sealants market.

What Are The Different Segment Classifications Within The Hemostats And Tissue Sealants Market?

The hemostats and tissue sealants market covered in this report is segmented –

1) By Product Type: Topical Hemostats, Adhesives And Tissue Sealants, Fibrin Sealants, Other Product Types

2) By Composition: Biological Based, Synthetic Based, Combination

3) By Distribution Channel: Direct Sales, Distributors, Online Sales

4) By Application: Surgical Procedures, Trauma Cases, Cardiovascular Surgery, General Surgery, Other Applications

5) By End-Users: Hospitals, Ambulatory Surgical Centers (ASCs), Specialized Clinics, Research And Academic Institutes

Subsegments:

1) By Topical Hemostats: Mechanical Hemostats, Active Hemostats, Flowable Hemostats, Combination Hemostats

2) By Adhesives And Tissue Sealants: Synthetic Tissue Adhesives, Biological Tissue Adhesives, Cyanoacrylate-Based Adhesives

3) By Fibrin Sealants: Liquid Fibrin Sealants, Patch-Based Fibrin Sealants

4) By Other Product Types: Gelatin-Based Hemostats, Collagen-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats

How Are Emerging Market Trends Shaping The Hemostats And Tissue Sealants Industry Landscape?

Leading companies in the hemostat and tissue sealants market are prioritizing the development of advanced products, such as ready-to-use absorbable collagen pads hemostat, to enhance efficiency and outcomes in surgical care. These ready-to-use absorbable collagen hemostat pads are characterized by bioactive, resorbable materials that allow for immediate application without prior preparation, facilitating quick and effective sealing of tissue and dura, as well as achieving hemostasis. For instance, in April 2025, Baxter International Inc., a US-based healthcare company, launched the Hemopatch Sealing Hemostat, designed for room temperature storage, at a symposium in Austria. This new room temperature Hemopatch sealing hemostat offers convenient readiness for use without requiring pre-warming, enabling rapid application during surgery. It is an innovative absorbable pad that can be directly applied during both open and minimally invasive surgeries, removing the necessity for product preparation or refrigeration. The product’s powerful adhesive qualities, extended shelf life, and fast hemostatic action aid surgeons in more efficiently managing bleeding or leakage, ultimately supporting improved surgical precision and patient recovery across diverse specialties.

Which Major Firms Are Strengthening Their Position In The Hemostats And Tissue Sealants Industry?

Major companies operating in the hemostats and tissue sealants market are Johnson & Johnson, Medtronic plc, Becton, Dickinson and Company (BD), Stryker Corporation, Baxter International Inc., Meril Life Sciences Pvt. Ltd., Teleflex Incorporated, Integra LifeSciences Holdings Corporation, Corza Medical Inc., Artivion Inc., Ethicon Inc., Advanced Medical Solutions Group plc, Marine Polymer Technologies Inc., Samyang Holdings Corporation, 3-D Matrix Medical Technology Co Ltd., GELITA AG, BioCer Entwicklungs-GmbH, AEGIS Lifesciences Pvt. Ltd., Betatech Medical Ltd., Cohera Medical Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/hemostats-and-tissue-sealants-global-market-report

Which Regional Markets Are Contributing Most To The Hemostats And Tissue Sealants Industry Expansion?

North America was the largest region in the hemostats and tissue sealants market in 2024. The regions covered in the hemostats and tissue sealants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Hemostats And Tissue Sealants Market Report:

https://www.thebusinessresearchcompany.com/customise?id=25781&type=smp

Browse Through More Reports Similar to the Global Hemostats And Tissue Sealants Market 2025, By The Business Research Company

Hemostats Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hemostats-global-market-report

Hemostasis Products Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hemostasis-products-global-market-report

Absorbable Hemostats Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/absorbable-hemostats-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Predicted Market Size Of The Hemostats And Tissue Sealants Industry By 2029?

In recent times, the market for hemostats and tissue sealants has seen a considerable expansion in its size. Projections assert that it will move from a market worth $4.07 billion in 2024 to reach a value of $4.35 billion in 2025, equating to a compound annual growth rate (CAGR) of 6.9%. The growth observed in history has been attributed to factors such as an aging population, a surge in trauma and accidents, a higher occurrence of cardiovascular disorders, an increase in medical investments, and the upsurge in preference for minimally invasive surgeries.

In the coming years, the market for hemostats and tissue sealants is predicted to experience substantial growth, reaching a worth of $5.61 billion in 2029 with a compound annual growth rate (CAGR) of 6.6%. The growth over this forecast period can be credited to factors such as the increasing utilization of hemostats in ambulatory surgical centers, growing demand for synthetic and biocompatible sealants, increased funding for research and development for surgical innovations, heightened awareness of blood management during operations, and escalating healthcare costs. Leading trends in the forecast period encompass progress in synthetic polymer technology, invention-driven advances in drug-delivery sealants, the incorporation of hemostatic agents in minimally invasive surgeries, emergence of dual-action hemostats and sealants, and improvements in bioengineered and biocompatible materials.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25781&type=smp

Which Industry Forces Are Driving The Hemostats And Tissue Sealants Market Forward?

The growth of the hemostats and tissue sealants market is anticipated to be fueled by the increasing number of surgical procedures. These procedures are medical operations performed by surgeons using manual and instrumental techniques, aiming to diagnose, treat, or remove unhealthy tissues or organs, or to repair body functions. The upsurge in surgical procedures can be attributed to the growing occurrence of chronic diseases often necessitating surgical intervention for effective management, treatment, or prevention of complications. Hemostats and tissue sealants play a crucial role in surgical procedures by proficiently managing bleeding and sealing tissues, which in turn minimizes complications and enhances surgical outcomes. For example, in June 2024, the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based board-certified professional organization for aesthetic plastic surgeons, reported an increase of 5.5% in surgical procedures in 2023, summing up to over 15.8 million surgeries and 19.1 million non-surgical procedures performed worldwide. Therefore, the escalating number of surgical procedures is stimulating the expansion of the hemostats and tissue sealants market.

What Is The Segment Breakdown Of The Hemostats And Tissue Sealants Market?

The hemostats and tissue sealants market covered in this report is segmented –

1) By Product Type: Topical Hemostats, Adhesives And Tissue Sealants, Fibrin Sealants, Other Product Types

2) By Composition: Biological Based, Synthetic Based, Combination

3) By Distribution Channel: Direct Sales, Distributors, Online Sales

4) By Application: Surgical Procedures, Trauma Cases, Cardiovascular Surgery, General Surgery, Other Applications

5) By End-Users: Hospitals, Ambulatory Surgical Centers (ASCs), Specialized Clinics, Research And Academic Institutes

Subsegments:

1) By Topical Hemostats: Mechanical Hemostats, Active Hemostats, Flowable Hemostats, Combination Hemostats

2) By Adhesives And Tissue Sealants: Synthetic Tissue Adhesives, Biological Tissue Adhesives, Cyanoacrylate-Based Adhesives

3) By Fibrin Sealants: Liquid Fibrin Sealants, Patch-Based Fibrin Sealants

4) By Other Product Types: Gelatin-Based Hemostats, Collagen-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats

How Are Global Trends Impacting The Development Of The Hemostats And Tissue Sealants Market?

Leading firms in the hemostat and tissue sealants market are prioritizing the development of advanced products, such as pre-prepared absorbable collagen hemostat pads, to enhance surgical care efficiency and results. These ready-to-use hemostat pads are equipped with bioactive, resorbable materials that permit immediate use without any pre-set preparation, aiding in quick and efficient tissue and dura sealing, in addition to hemostasis. For example, a healthcare company based in the US, Baxter International Inc., introduced Hemopatch Sealing Hemostat, which can be stored at room temperature, in Austria during a symposium in April 2025. This room-temperature Hemopatch sealing hemostat offers immediate utilization without the need for pre-heating, facilitating swift application during surgical procedures. It is a groundbreaking absorbable pad that can be directly applied during both major and minimally invasive surgeries, bypassing the requirement for product preparation or refrigeration. The product’s potent adhesive abilities, prolonged shelf life, and quick hemostatic reaction assist surgeons in controlling bleeding or leakage more effectively, ultimately contributing to enhanced surgical accuracy and patient recuperation across diverse specialties.

Which Companies Are Contributing Significantly To The Hemostats And Tissue Sealants Market Growth?

Major companies operating in the hemostats and tissue sealants market are Johnson & Johnson, Medtronic plc, Becton, Dickinson and Company (BD), Stryker Corporation, Baxter International Inc., Meril Life Sciences Pvt. Ltd., Teleflex Incorporated, Integra LifeSciences Holdings Corporation, Corza Medical Inc., Artivion Inc., Ethicon Inc., Advanced Medical Solutions Group plc, Marine Polymer Technologies Inc., Samyang Holdings Corporation, 3-D Matrix Medical Technology Co Ltd., GELITA AG, BioCer Entwicklungs-GmbH, AEGIS Lifesciences Pvt. Ltd., Betatech Medical Ltd., Cohera Medical Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/hemostats-and-tissue-sealants-global-market-report

Which Region Is Leading Innovation In The Hemostats And Tissue Sealants Market?

North America was the largest region in the hemostats and tissue sealants market in 2024. The regions covered in the hemostats and tissue sealants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=25781&type=smp

Browse Through More Reports Similar to the Global Hemostats And Tissue Sealants Market 2025, By The Business Research Company

Surgical Sealants And Adhesives Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/surgical-sealants-and-adhesives-market

Dental Adhesives And Sealants Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dental-adhesives-and-sealants-global-market-report

Pharmaceutical Processing Seals Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pharmaceutical-processing-seals-global-market-report

About The Business Research Company:

With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Outlook for the Hemostats And Tissue Sealants Market Heading Into 2029?

In the past few years, there has been a substantial growth in the market size of hemostats and tissue sealants. The market is projected to increase from $4.07 billion in 2024 to $4.35 billion in 2025, following a compound annual growth rate (CAGR) of 6.9%. The previous growth can be linked to factors such as the increasing older population, higher occurrences of accidents and trauma, a rising number of cardiovascular conditions, growing investments in the medical sector, and the escalating preference for minimally invasive surgeries.

The market for hemostats and tissue sealants is on course to experience robust expansion in the coming few years, with the valuation climbing to $5.61 billion in 2029, having a compound annual growth rate (CAGR) of 6.6%. Factors propelling this growth during the forecast period include the increasing utilization of hemostats in outpatient surgery facilities, surging demand for biocompatible and synthetic sealants, elevated investment in surgical innovations and R&D, heightened awareness regarding blood management in surgeries, and rising healthcare spendings. Key trends set to dominate the forecast period are the improvements in synthetic polymer technology, technological advancements in drug-delivery sealants, the incorporation of hemostatic agents in minimally invasive surgeries, progress in dual-action sealants and hemostats, and advancements in bioengineered and biocompatible materials.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25781&type=smp

Which Factors Are Pushing The Hemostats And Tissue Sealants Market Forward?

The growth of the hemostats and tissue sealants market is projected to be spurred by the increased number of surgical procedures. Surgical procedures are defined as medical operations that involve manual and instrumental techniques used by surgeons to diagnose, treat or remove diseased tissues or organs, or correct bodily functions. This increase in surgeries is primarily caused by the prevalence of chronic diseases that require surgical measures for successful management, treatment, or the prevention of complications. Hemostats and tissue sealants play a critical role in surgeries by effectively controlling bleeding and sealing tissues, which results in decreased complications and enhanced surgical results. For example, according to the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based professional organization for board-certified aesthetic plastic surgeons, there was a 5.5% increase in surgical procedures in 2023, with over 15.8 million surgeries and 19.1 million non-surgical procedures conducted worldwide. Hence, the increased number of surgeries is propelling the growth of the hemostats and tissue sealants market.

Which Segment Held The Largest Share In The Hemostats And Tissue Sealants Market In 2025?

The hemostats and tissue sealants market covered in this report is segmented –

1) By Product Type: Topical Hemostats, Adhesives And Tissue Sealants, Fibrin Sealants, Other Product Types

2) By Composition: Biological Based, Synthetic Based, Combination

3) By Distribution Channel: Direct Sales, Distributors, Online Sales

4) By Application: Surgical Procedures, Trauma Cases, Cardiovascular Surgery, General Surgery, Other Applications

5) By End-Users: Hospitals, Ambulatory Surgical Centers (ASCs), Specialized Clinics, Research And Academic Institutes

Subsegments:

1) By Topical Hemostats: Mechanical Hemostats, Active Hemostats, Flowable Hemostats, Combination Hemostats

2) By Adhesives And Tissue Sealants: Synthetic Tissue Adhesives, Biological Tissue Adhesives, Cyanoacrylate-Based Adhesives

3) By Fibrin Sealants: Liquid Fibrin Sealants, Patch-Based Fibrin Sealants

4) By Other Product Types: Gelatin-Based Hemostats, Collagen-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats

How Are Key Trends Driving Expansion In The Hemostats And Tissue Sealants Industry?

Leading firms in the hemostat and tissue sealants market are now prioritizing the invention of enhanced products such as ready-to-use absorbable collagen pad hemostat to optimize efficiency and subsequent results in surgical procedures. This type of hemostat, made from biologically active, resorbable components, can be applied immediately without any prior preparation, providing an efficient mechanism for tissue and dura sealing alongside hemostasis. Specifically, Baxter International Inc., a healthcare company based in the United States, launched Hemopatch Sealing Hemostat with ambient temperature storage at a symposium held in Austria in April 2025. This novel room-temperature Hemopatch sealing hemostat eliminates the requirement for pre-warming, facilitating speedy application amid surgeries. This innovative absorbable pad could be employed directly in both open and minimally invasive procedures, obviating the requirement for product preparation or refrigeration. The robust adhesive attributes, extended lifespan, and prompt hemostatic impact of the product assist surgeons in managing leakage or bleeding more effectively. This contributes to improved surgical accuracy and patient recovery across a variety of specializations.

Which Organizations Are Driving Progress In The Hemostats And Tissue Sealants Industry?

Major companies operating in the hemostats and tissue sealants market are Johnson & Johnson, Medtronic plc, Becton, Dickinson and Company (BD), Stryker Corporation, Baxter International Inc., Meril Life Sciences Pvt. Ltd., Teleflex Incorporated, Integra LifeSciences Holdings Corporation, Corza Medical Inc., Artivion Inc., Ethicon Inc., Advanced Medical Solutions Group plc, Marine Polymer Technologies Inc., Samyang Holdings Corporation, 3-D Matrix Medical Technology Co Ltd., GELITA AG, BioCer Entwicklungs-GmbH, AEGIS Lifesciences Pvt. Ltd., Betatech Medical Ltd., Cohera Medical Inc.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/hemostats-and-tissue-sealants-global-market-report

Which Region Is Expected To Experience The Highest Growth In The Hemostats And Tissue Sealants Industry?

North America was the largest region in the hemostats and tissue sealants market in 2024. The regions covered in the hemostats and tissue sealants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=25781&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model